Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Non-alcoholic fatty liver disease : a 360-degree overview / / Elisabetta Bugianesi, editor
| Non-alcoholic fatty liver disease : a 360-degree overview / / Elisabetta Bugianesi, editor |
| Edizione | [1st ed. 2020.] |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2020] |
| Descrizione fisica | 1 online resource (X, 362 p. 45 illus., 41 illus. in color.) |
| Disciplina | 616.362 |
| Soggetto topico | Fatty liver |
| ISBN | 3-319-95828-3 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction -- Obesity and NAFLD: same problem? The burden of NAFLD worldwide -- Histo-pathology of NAFLD -- NAFLD and insulin resistance: a multisystemic -- Etiopathogenesis of NAFLD: diet, gut and NASH -- Etiopathogenesis of NAFLD: molecular mechanisms of fibrogenesis -- The natural history of NAFLD: Environmental vs Genetic Risk Factors -- NAFLD and endocrine disease: clinical implications -- NAFLD and Cardiovascular Disease: clinical implications -- NAFLD, Hepatocellular Carcinoma and extrahepatic cancers -- NAFLD in children: implications for the future -- Diagnostic algorithm for the identification of NAFLD in primary care -- Non-Invasive diagnostic approach to NASH: Biological Markers -- Non-Invasive diagnostic approach to NASH: Radiological Diagnostics -- Dietary approach to NAFLD -- Physical Activity in NAFLD: what and how much? Pharmacological Therapy of NASH -- Bariatric Surgery and NASH: a feasible option? Liver transplantation and NASH -- Unmet needs and future goals. |
| Record Nr. | UNINA-9910420947303321 |
| Cham, Switzerland : , : Springer, , [2020] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Non-alcoholic fatty liver disease : molecular bases, prevention and treatment / / Rodrigo Valenzuela Baez, editor
| Non-alcoholic fatty liver disease : molecular bases, prevention and treatment / / Rodrigo Valenzuela Baez, editor |
| Pubbl/distr/stampa | [Place of publication not identified] : , : IntechOpen, , [2018] |
| Descrizione fisica | 1 online resource (190 pages) |
| Disciplina | 616.362 |
| Soggetto topico | Fatty liver |
| ISBN |
953-51-4029-9
953-51-3924-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Non-alcoholic fatty liver disease |
| Record Nr. | UNINA-9910265145103321 |
| [Place of publication not identified] : , : IntechOpen, , [2018] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Non-alcoholic fatty liver disease [[electronic resource] ] : a practical guide / / edited by Geoffrey C. Farrell, Arthur J. McCullough, Christopher P. Day
| Non-alcoholic fatty liver disease [[electronic resource] ] : a practical guide / / edited by Geoffrey C. Farrell, Arthur J. McCullough, Christopher P. Day |
| Pubbl/distr/stampa | Chichester [England], : Wiley-Blackwell, 2013 |
| Descrizione fisica | 1 online resource (x, 313 pages, [4] pages of plates) : illustrations (some color) |
| Disciplina | 616.3/62 |
| Altri autori (Persone) |
FarrellGeoffrey C
McCulloughArthur J DayChristopher Paul |
| Soggetto topico |
Fatty liver
Liver - Diseases |
| ISBN |
1-299-15960-5
1-118-55621-6 1-118-55615-1 1-118-55622-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910208837003321 |
| Chichester [England], : Wiley-Blackwell, 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Non-alcoholic fatty liver disease [[electronic resource] ] : a practical guide / / edited by Geoffrey C. Farrell, Arthur J. McCullough, Christopher P. Day
| Non-alcoholic fatty liver disease [[electronic resource] ] : a practical guide / / edited by Geoffrey C. Farrell, Arthur J. McCullough, Christopher P. Day |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Chichester [England], : Wiley-Blackwell, 2013 |
| Descrizione fisica | 1 online resource (x, 313 pages, [4] pages of plates) : illustrations (some color) |
| Disciplina | 616.3/62 |
| Altri autori (Persone) |
FarrellGeoffrey C
McCulloughArthur J DayChristopher Paul |
| Soggetto topico |
Fatty liver
Liver - Diseases |
| ISBN |
1-299-15960-5
1-118-55621-6 1-118-55615-1 1-118-55622-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover -- Title page -- Copyright page -- Contents -- List of Contributors -- Chapter 1: What is non-alcoholic fatty liver disease (NAFLD), and why is it important? -- What is NAFLD? -- What is non-alcoholic? -- Steatosis and NASH -- Pathological definition of NASH -- NASH without inflammation or fat? The special case of cryptogenic cirrhosis -- Does NAFLD matter? -- Do recent advances allow us to suggest a better name than NAFLD? -- What isn't NAFLD? -- A practical (clinical) definition of NAFLD -- Need for consensus of definitions -- Is NAFLD an epidemic, and how common is NASH? -- Risk factors -- Who gets NAFLD? -- Who gets NASH? -- Presentation, clinical features, and associated disorders -- Can we prevent NAFLD? -- Reversibility of NASH: perspectives on lifestyle, obesity interventions, and drug therapy -- Multiple choice questions -- References -- Answers to multiple choice questions -- Chapter 2: NAFLD in the community -- Introduction -- Defining NAFLD -- Diagnosing NAFLD -- NASH -- Prevalence of NAFLD -- Worldwide prevalence -- Age -- Gender -- Race, ethnicity, and genes -- Diabetes mellitus -- Obesity -- Conclusions -- Multiple Choice Questions -- References -- Answers to multiple choice questions -- Chapter 3: Pathology of NAFLD -- Introduction -- Adult fatty liver disease -- Fibrosis patterns -- Is NAFLD "identical" to ALD? -- NAFLD in children -- Evaluation of NAFLD and NASH: staging and grading -- Technical liver biopsy considerations -- Multiple choice questions -- References -- Answers to multiple choicequestions -- Chapter 4: The natural history of NAFLD -- Introduction -- Long-term prognosis of patients with the whole spectrum of NAFLD -- Long-term prognosis of patients with simple steatosis or non-alcoholic steatohepatitis (NASH) -- Long-term prognosis of patients with NAFLD with advanced fibrosis and cirrhosis.
Fibrosis progression in patients with NAFLD -- Conclusions and future directions -- Multiple choice questions -- References -- Answers to multiple choicequestions -- Chapter 5: Emerging concepts on the pathogenesis of non-alcoholic steatohepatitis (NASH) -- Introduction -- Part 1: The fatty liver and the metabolic context of obesity -- Mechanisms for liver fat accumulation -- Links between steatosis, insulin resistance, and activation of pro-inflammatory pathways -- Consequences of insulin resistance in the liver -- Part 2: Evolution from steatosis to NASH: what do we know about pathogenic determinants? -- A Continuum, or pathogenically different entities? -- Reactive oxygen species -- Do lipids promote the progression from steatosis to steatohepatitis? -- The adipose tissue -- Is NASH a manifestation of the innate immunity? -- Concluding comments and agenda for future research -- Multiple choice questions -- References -- Answers to multiple choice questions -- Chapter 6: Diabetes and NAFLD: why is the connection important? -- Introduction -- Fatty liver is a major determinant of insulin resistance and the metabolic syndrome -- NAFLD and risk of developing type 2 diabetes -- NAFLD, diabetes severity, and microvascular chronic complications -- Liver-related morbidity and mortality in type 2 diabetes -- Diabetes and hepatocellular carcinoma -- Implications for treatment -- Conclusion and future perspectives -- Multiple choice questions -- References -- Answers to multiple choice questions -- Chapter 7: NAFLD and cardiovascular risk factors: implications for vascular disease -- Introduction -- NAFLD and CVD risk factors -- NAFLD and increased prevalence of CVD -- NAFLD and increased incidence of CVD -- NAFLD and CVD: causal effect or epiphenomenon? -- Conclusions -- Multiple choice questions -- References -- Answers to multiple choice questions. Chapter 8: A primary care perspective of fatty liver: diagnosis, management, prescribing, and when to refer -- Introduction: fatty liver and the metabolic syndrome -- Diagnosis -- Imaging -- Liver function tests -- Evaluation -- History and physical examination -- Alcohol -- Physical examination -- Laboratory tests -- Testing for metabolic disorders -- When to refer -- Management -- Statins and hyperlipidemia -- Use of other medications -- Follow-up -- Conclusions -- Multiple choice questions -- References -- Answers to multiple choice questions -- Chapter 9: Imaging of NAFLD -- Introduction -- Imaging evaluation of hepatic steatosis -- Ultrasound -- Computed tomography -- Magnetic resonance -- Comparative performance of US, CT, and MR -- Imaging evaluation of fibrosis and cirrhosis -- Stiffness -- Perfusion -- Diffusion -- Imaging evaluation of non-alcoholic steatohepatitis -- Conclusion -- Multiple choice questions -- References -- Answers to multiple choice questions -- Chapter 10: Non-invasive methods to determine the severity of NAFLD and NASH -- Introduction -- Liver biopsy -- Non-invasive assessment of hepatic steatosis -- Radiological tests -- Other clinical tests -- Non-invasive assessment of NASH -- Clinical parameters -- Biomarkers of apoptosis -- Adipokines -- Biomarkers of oxidative stress -- Other biomarkers -- Non-invasive assessment of fibrosis -- Clinical prediction scores -- Biomarkers of fibrosis -- Physical measurements -- The future -- Multiple choice questions -- References -- Answers to multiple choice questions -- Chapter 11: Fatigue, quality of life, and psychosocial issues for people with NAFLD -- Functional ability in NAFLD -- Symptoms in NAFLD -- Fatigue in NAFLD -- Excessive daytime sleepiness -- Autonomic nervous system dysfunction -- Postural dizziness -- Depression in patients with NAFLD. Engagement in physical activity -- Management of symptoms experienced by patients with NAFLD -- Multiple choice questions -- References -- Answers to multiple choice questions -- Chapter 12: Physical activity and cardiovascular fitness in patients with NAFLD: clinical importance and therapeutic implications -- Overview of physical activity, exercise, physical fitness, and energy expenditure -- Endurance-aerobic training -- Interval training (aerobic and anaerobic) -- Resistance training -- Importance of physical activity for health - being sedentary and/or inactive -- Measuring physical activity and assessing physical fitness -- Potential metabolic and other benefits of exercise in NAFLD -- Physical activity and fitness in NAFLD -- Intervention studies in NAFLD -- Exercise as a treatment for NAFLD in children and adolescents -- Impediments to exercise in NAFLD -- Future perspectives for exercise in the treatment of NAFLD -- Conclusion -- Multiple choice questions -- References -- Answers to multiple choice questions -- Chapter 13: NAFLD, obesity, and bariatric surgery -- Severe obesity and bariatric surgery -- Non-alcoholic fatty liver disease (NAFLD) and bariatric surgery -- Pretreatment histology -- Predictors of disease severity -- Efficacy -- Closing comments -- Multiple choice questions -- References -- Answers to multiple choice questions -- Chapter 14: Genetic predisposition to NAFLD and NASH: implications for pathogenesis, diagnosis, prevention, and management -- Introduction -- Genome-wide association studies in NAFLD and NASH research -- Romeo et al. (2008) -- Chalasani et al. (2010) -- Speliotes et al. (2011) -- Genetic modifiers of NAFLD pathogenesis and progression -- Genetic modifiers of metabolic syndrome risk -- Genetic modifiers of hepatic fatty acid flux and triglyceride levels -- Genetic modifiers of progression to steatohepatitis. Genetic modifiers of fibrogenesis and disease progression -- Conclusions -- Multiple choice questions -- References -- Answers to multiple choice questions -- Chapter 15: NAFLD in children -- Epidemiology -- Natural history -- Signs and symptoms -- Diagnosis -- Liver biopsy -- Blood biomarkers -- Imaging techniques -- Treatment -- Nonpharmacological interventions -- Medications -- Insulin-sensitizing agents -- Hepatoprotective anti-oxidant therapy -- Other therapies -- Conclusions -- Multiple choice questions -- References -- Answers to multiple choice questions -- Chapter 16: The pointy end of the NAFLD iceberg: cirrhosis, portal hypertension, and liver failure -- Disclaimer -- Introduction -- Epidemiology -- Progression of NASH to cirrhosis -- Cryptogenic cirrhosis -- Histopathology of late NAFLD and cirrhosis -- Clinical outcomes of advanced NAFLD and cirrhosis -- Diagnosis and presentation -- Treatment of NAFLD cirrhosis and complications -- Transplant considerations -- Conclusions and future directions -- Multiple choice questions -- References -- Answers to multiple choice questions -- Chapter 17: Non-alcoholic fatty liver disease, hepatocellular cancer, and other cancers -- Incidence and epidemiology of HCC -- Risk factors for HCC -- NAFLD, metabolic syndrome, and HCC -- HCC can develop in noncirrhotic NAFLD -- NAFLD, the metabolic syndrome, and other cancers -- Obesity and cancer -- Diabetes and cancer -- The pathogenesis of HCC in NAFLD -- The management of HCC arising in patients with the metabolic syndrome -- Surveillance -- The diagnosis of HCC -- Staging of HCC -- Treatment options for HCC -- Surgical resection -- Liver transplantation -- Percutaneous treatments -- Transcatheter arterial chemoembolization (TACE) -- Medical management of HCC -- A modified BCLC algorithm for patients with NAFLD and the metabolic syndrome. Future directions. |
| Record Nr. | UNINA-9910816917203321 |
| Chichester [England], : Wiley-Blackwell, 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Non-Alcoholic Fatty Liver Disease Research 2016 / / Amedeo Lonardo and Giovanni Targher
| Non-Alcoholic Fatty Liver Disease Research 2016 / / Amedeo Lonardo and Giovanni Targher |
| Autore | Lonardo Amedeo |
| Pubbl/distr/stampa | Basel, Switzerland : , : MDPI - Multidisciplinary Digital Publishing Institute, , 2018 |
| Descrizione fisica | 1 online resource (566 pages) |
| Disciplina | 616.362 |
| Soggetto topico |
Fatty liver
Diseases |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910674013403321 |
Lonardo Amedeo
|
||
| Basel, Switzerland : , : MDPI - Multidisciplinary Digital Publishing Institute, , 2018 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Nonalcoholic Fatty Liver Disease : An Update / / edited by Emad Hamdy Gad
| Nonalcoholic Fatty Liver Disease : An Update / / edited by Emad Hamdy Gad |
| Pubbl/distr/stampa | London : , : IntechOpen, , 2019 |
| Descrizione fisica | 1 online resource (144 pages) : illustrations |
| Disciplina | 616.362 |
| Soggetto topico | Fatty liver |
| ISBN | 1-83962-870-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Nonalcoholic Fatty Liver Disease |
| Record Nr. | UNINA-9910407745003321 |
| London : , : IntechOpen, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Nonalcoholic fatty liver disease (NAFLD) / / edited by Tatjana Abel & Gabriella Lengyel
| Nonalcoholic fatty liver disease (NAFLD) / / edited by Tatjana Abel & Gabriella Lengyel |
| Pubbl/distr/stampa | Sharjah, United Arab Emirates : , : Bentham Science Publishers, , 2017 |
| Descrizione fisica | 1 online resource (178 pages) |
| Disciplina | 616.362 |
| Soggetto topico |
Fatty liver
Insulin resistance |
| ISBN | 1-68108-465-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910792961403321 |
| Sharjah, United Arab Emirates : , : Bentham Science Publishers, , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Nonalcoholic fatty liver disease (NAFLD) / / edited by Tatjana Abel & Gabriella Lengyel
| Nonalcoholic fatty liver disease (NAFLD) / / edited by Tatjana Abel & Gabriella Lengyel |
| Pubbl/distr/stampa | Sharjah, United Arab Emirates : , : Bentham Science Publishers, , 2017 |
| Descrizione fisica | 1 online resource (178 pages) |
| Disciplina | 616.362 |
| Soggetto topico |
Fatty liver
Insulin resistance |
| ISBN | 1-68108-465-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910808526803321 |
| Sharjah, United Arab Emirates : , : Bentham Science Publishers, , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pathophysiology of nonalcoholic steatohepatitis [[electronic resource] /] / Metin Basaranoglu and Brent A. Neuschwander-Tetri
| Pathophysiology of nonalcoholic steatohepatitis [[electronic resource] /] / Metin Basaranoglu and Brent A. Neuschwander-Tetri |
| Autore | Basaranoglu Metin |
| Pubbl/distr/stampa | New York, : Nova Biomedical Books, c2009 |
| Descrizione fisica | 1 online resource (122 p.) |
| Altri autori (Persone) | Neuschwander-TetriBrent A |
| Soggetto topico |
Liver - Diseases
Fatty liver |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-60741-390-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""PATHOPHYSIOLOGY OFNONALCOHOLICSTEATOHEPATITIS""; ""NOTICE TO THE READER""; ""CONTENTS""; ""PREFACE""; ""ABBREVIATIONS""; ""PATHOPHYSIOLOGY OF EXCESSIVE FATACCUMULATION IN THE LIVER IN THEABSENCE OF ALCOHOL ABUSE: NAFLD""; ""OBESITY, INSULIN RESISTANCE ANDHYPERINSULINEMIA AS RISK FACTORS FOR NAFLD""; ""SOURCES OF LIVER FAT""; ""Dysregulated Peripheral Lipolysis""; ""Hepatic de Novo Lipogenesis (DNL)""; ""Uptake of Dietary Fat into the Liver""; ""FATES OF LIVER FAT""; ""Very-low-density Lipoprotein (VLDL) Synthesis and Secretion""; ""Mitochondrial β-Oxidation""
""Peroxisomal Fatty Acid β-Oxidation""""Cytochrome P450 Fatty Acid Ï? (Omega)-Oxidation""; ""Local and Generalized Inflammation in NAFLD""; ""NASH: THE PATHOGENESIS OFHEPATOCELLULAR INJURY IN NAFLD""; ""ROLE OF ANIMAL MODELS IN UNDERSTANDING THEPATHOGENESIS OF NASH""; ""The ob/ob Mouse""; ""The Methionine and Choline Deficient (MCD) Diet""; ""Other Dietary Models""; ""Transition from Simple Steatosis and NASH to NASH-AssociatedHCC: A new Murine NASH-Associated Hepatic Neoplasia Mo""; ""OXIDATIVE STRESS AND THE PATHOGENESIS OFNASH""; ""Mitochondria as a Source of Oxidant Stress"" ""P450 as a Source of Oxidant Stress""""Iron, Oxidant Stress and NASH""; ""MITOCHONDRIAL DYSFUNCTION AND ATPDEPLETION""; ""FREE FATTY ACID TOXICITY""; ""ENDOGENOUS TOXINS:ENDOTOXIN AND GUT-DERIVED ETHANOL""; ""ADIPOCYTOKINES""; ""Leptin""; ""Adiponectin""; ""TNF-α""; ""IL-6""; ""Resistin""; ""Regulation of Hepatic Immunity and Increased Sensitivity toHepatocellular Injury""; ""HEPATOCYTE APOPTOSIS IN NAFLD""; ""HEPATIC FIBROGENESIS IN NASH""; ""ROLE OF STELLATE CELLS AND CYTOKINES INHEPATIC FIBROGENESIS""; ""HEPATOCELLULAR CARCI""; ""PATHOPHYSIOLOGY OF THEPATHOLOGICAL FEATURES OF NASH"" ""MICROVESICULAR AND MACROVESICULAR STEATOSIS""""INFLAMMATION""; ""GLYCOGEN NUCLEI""; ""LIPOGRANULOMAS""; ""HEPATOCELLULAR BALLOONI""; ""HEPATOCELLULAR BALLOONING""; ""MALLORY BODIES AND STRESS PROTEINS""; ""GENETIC SUSCEPTIBILITY TO NASH AND THE BASISOF NASH-PATHOPHYSIOLOGY""; ""NASH Prevalence in Different Racial and Ethnic Groups""; ""NAFLD and Genes Associated with Lipid and Glucose Metabolism,Oxidant and Anti-Oxidant Systems, and ProinflammatoryCytokines""; ""SUMMARY""; ""REFERENCES""; ""INDEX"" |
| Record Nr. | UNINA-9910454575003321 |
|
Basaranoglu Metin
|
||
| New York, : Nova Biomedical Books, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pathophysiology of nonalcoholic steatohepatitis [[electronic resource] /] / Metin Basaranoglu and Brent A. Neuschwander-Tetri
| Pathophysiology of nonalcoholic steatohepatitis [[electronic resource] /] / Metin Basaranoglu and Brent A. Neuschwander-Tetri |
| Autore | Basaranoglu Metin |
| Pubbl/distr/stampa | New York, : Nova Biomedical Books, c2009 |
| Descrizione fisica | 1 online resource (122 p.) |
| Altri autori (Persone) | Neuschwander-TetriBrent A |
| Soggetto topico |
Liver - Diseases
Fatty liver |
| ISBN | 1-60741-390-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""PATHOPHYSIOLOGY OFNONALCOHOLICSTEATOHEPATITIS""; ""NOTICE TO THE READER""; ""CONTENTS""; ""PREFACE""; ""ABBREVIATIONS""; ""PATHOPHYSIOLOGY OF EXCESSIVE FATACCUMULATION IN THE LIVER IN THEABSENCE OF ALCOHOL ABUSE: NAFLD""; ""OBESITY, INSULIN RESISTANCE ANDHYPERINSULINEMIA AS RISK FACTORS FOR NAFLD""; ""SOURCES OF LIVER FAT""; ""Dysregulated Peripheral Lipolysis""; ""Hepatic de Novo Lipogenesis (DNL)""; ""Uptake of Dietary Fat into the Liver""; ""FATES OF LIVER FAT""; ""Very-low-density Lipoprotein (VLDL) Synthesis and Secretion""; ""Mitochondrial β-Oxidation""
""Peroxisomal Fatty Acid β-Oxidation""""Cytochrome P450 Fatty Acid Ï? (Omega)-Oxidation""; ""Local and Generalized Inflammation in NAFLD""; ""NASH: THE PATHOGENESIS OFHEPATOCELLULAR INJURY IN NAFLD""; ""ROLE OF ANIMAL MODELS IN UNDERSTANDING THEPATHOGENESIS OF NASH""; ""The ob/ob Mouse""; ""The Methionine and Choline Deficient (MCD) Diet""; ""Other Dietary Models""; ""Transition from Simple Steatosis and NASH to NASH-AssociatedHCC: A new Murine NASH-Associated Hepatic Neoplasia Mo""; ""OXIDATIVE STRESS AND THE PATHOGENESIS OFNASH""; ""Mitochondria as a Source of Oxidant Stress"" ""P450 as a Source of Oxidant Stress""""Iron, Oxidant Stress and NASH""; ""MITOCHONDRIAL DYSFUNCTION AND ATPDEPLETION""; ""FREE FATTY ACID TOXICITY""; ""ENDOGENOUS TOXINS:ENDOTOXIN AND GUT-DERIVED ETHANOL""; ""ADIPOCYTOKINES""; ""Leptin""; ""Adiponectin""; ""TNF-α""; ""IL-6""; ""Resistin""; ""Regulation of Hepatic Immunity and Increased Sensitivity toHepatocellular Injury""; ""HEPATOCYTE APOPTOSIS IN NAFLD""; ""HEPATIC FIBROGENESIS IN NASH""; ""ROLE OF STELLATE CELLS AND CYTOKINES INHEPATIC FIBROGENESIS""; ""HEPATOCELLULAR CARCI""; ""PATHOPHYSIOLOGY OF THEPATHOLOGICAL FEATURES OF NASH"" ""MICROVESICULAR AND MACROVESICULAR STEATOSIS""""INFLAMMATION""; ""GLYCOGEN NUCLEI""; ""LIPOGRANULOMAS""; ""HEPATOCELLULAR BALLOONI""; ""HEPATOCELLULAR BALLOONING""; ""MALLORY BODIES AND STRESS PROTEINS""; ""GENETIC SUSCEPTIBILITY TO NASH AND THE BASISOF NASH-PATHOPHYSIOLOGY""; ""NASH Prevalence in Different Racial and Ethnic Groups""; ""NAFLD and Genes Associated with Lipid and Glucose Metabolism,Oxidant and Anti-Oxidant Systems, and ProinflammatoryCytokines""; ""SUMMARY""; ""REFERENCES""; ""INDEX"" |
| Record Nr. | UNINA-9910778034003321 |
|
Basaranoglu Metin
|
||
| New York, : Nova Biomedical Books, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Soggetto topico
-
Fatty liver
(21)
- Liver - Diseases (7)
- Insulin resistance (5)
- Diseases (1)